Skip to main content

Table 1 Subject characteristics (n = 51)a

From: Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis

Variable

Subjects

Control (N, %)

CTD-IP (N, %)

P-Value

Total

51

23 (45.1)

28 (54.9)

 

Age

   

0.723

≥50 years

28

12 (42.9)

16 (57.1)

 

<50 years

23

11 (47.8)

12 (52.2)

 

Gender

   

0.654

Male

22

10 (45.5)

12 (54.5)

 

Female

29

13 (44.8)

16 (55.2)

 
  1. aData are expressed as number (percentage)